期刊名称：ALZHEIMER DISEASE & ASSOCIATED DISORDERS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Alzheimer Disease & Associated Disorders is a leading international forum for reports of new research findings and new approaches to diagnosis and treatment. Contributions fall within all relevant scientific fields and clinical specialties, including neurobiology, neurochemistry, molecular biology, neurology, neuropathology, neuropsychology, psychiatry, gerontology, and geriatrics.
Instructions to Authors
Alzheimer Disease & Associated Disorders is a peer-reviewed, multidisciplinary journal directed to an audience of physicians, with primary emphasis on Alzheimer disease and associated disorders. The journal publishes original articles in the form of clinical and basic research and scientific advances. The scientific portion of the journal is augmented by reports on legislative actions as well as pending legislation that could have an impact on research funding, brief accounts of transactions at various national and international conferences, and abstracts of current relevant literature.
Ethical/Legal Considerations
A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the journal, its editors, or the publisher. All manuscripts must be submitted on-line through the Journal Web site at http://adad.edmgr.com. See submission instructions under "On-line manuscript submission."
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Copyright: All authors must sign a copy of the journal's "Authorship Responsibility, Financial Disclosure, and Copyright Transfer" form and submit it with the original manuscript. A copy of the form can be obtained by clicking on the following link: https://ww1.editorialmanager.com/adad/accounts/ctrans.doc.
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
On-line manuscript submission: All manuscripts must be submitted on-line through the new Web site at http://adad.edmgr.com.
First-time users: Please click the Register button from the main menu and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor).
Authors: Please click the Log in button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you are unable to submit your manuscript electronically or experience any other problems, please contact: Beverly Huizar, adad@abraxas.wustl.edu.
Title page: Include on the title page (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) sources of support that require acknowledgment.
The title page must also include disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Unstructured abstract and key words: Limit the abstract to 200 words. It must be factual and comprehensive. Limit the use of abbreviations and acronyms, and avoid general statements (eg, 'the significance of the results is discussed'). List three to six key words or phrases.
Text: Organize the manuscript into four main headings: Introduction, Methods, Results, and Discussion. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city and state/country). Acknowledge all forms of support, including pharmaceutical and industry support, in an Acknowledgments paragraph.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. Key the references (double-spaced) at the end of the manuscript. References should be numbered in the order of their first citation in the text; do not alphabetize. Identify with superscript Arabic numerals. Cite unpublished data, such as papers submitted but not yet accepted for publication or personal communications, in parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
Reference Style: Follow the AMA Manual of Style, 9th edition, for styling references, as follows (note that the exception to AMA style is to use et al after naming only 3 authors):
Journal
1. Davis JT, Allen HD, Powers JD, et al. Population requirements for capitation planning in cardiac surgery. Arch Pediatr Adolesc Med. 1996;150:257-259.
Chapter in a book
2. Nahas GG, Goldfrank LR. Marijuana. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies. 5th ed. Norwalk, CT: Appleton & Lange; 1994:889-N898.
Book
3. Sherlock S, Dooley J. Diseases of the Liver and Biliary System. 9th ed. Oxford, England: Blackwell Scientific Publications; 1993.
Software
Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention, 1994.
Online journals
Friedman SA: Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-N37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute, 1996. Updated March 29, 1996.
World Wide Web
Gostin LO: Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.
Figures
Digital figures: Electronic art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated postscript) file, or a PPT (Power Point) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographs - radiographs, CT scans, and so on - and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. Please note that artwork generated from office suite programs such Corel Draw and MS Word and artwork downloaded from the Internet (JPEG or GIFF files) cannot be used.
Figure legends: Legends must be submitted for all figures. They should be brief and specific, and should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.
Color figures: The journal accepts for publication color figures that will enhance an article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
Tables: Create tables using the table creating and editing feature of your word processing software (eg, Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Group all tables at the end of the manuscript, or supply them together in a separate file. Cite tables consecutively in the text and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location city and state in USA; city and country outside USA) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units.
After Acceptance:
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) will be sent to the corresponding author via e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected pages to the publisher. Those authors without an e-mail address will receive traditional page proofs.
It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Fax or mail your order to Lippincott Williams & Wilkins, Author Reprint Department, 351 West Camden Street, Baltimore, MD 21201. Fax: 410-528-4434. Rapid Ordering can be accessed at http://www.lww.com/periodicals/author-reprints. A confirmation of your order will be e-mailed to you. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Author Reprint Department with any questions.
Publisher's contact: Fax corrected page proofs and any other related materials to Proof Manager, Alzheimer Disease & Associated Disorders, 1-866-978-5767.
Manuscript Submission Checklist (before submission):
Cover letter addressed to the editor
Title page
Abstract
In-text references indicated with superscript Arabic numerals
References double-spaced in AMA style
Corresponding author designated, and full mailing address included in cover letter and on title page
Email address of corresponding author included in cover letter and on title page
Permission to reproduce copyrighted materials or signed patient consent forms
Acknowledgments listed for grants and technical support
High-quality electronic art
Tables created using table software feature
Editorial Board
Editor-in-Chief
Charles DeCarli, MD
Department of Neurology
Director, Alzheimer’s Disease Center
University of California, Davis Medical Center
4860 Y Street, Suite 3700
Sacramento, California 95817
Phone: 916-734-8413
Fax: 916-734-6525
charles.decarli@ucdmc.ucdavis.edu
Associate Editors for Neuroscience
Samuel E. Gandy,
New York, New York
Rajesh N. Kalaria,
Newcastle upon Tyne, UK
Associate Editor for Book Reviews
Philip Scheltens,
Amsterdam, Netherlands
Associate Editor for Statistics
Danielle Harvey, PhD,
Davis, CA
Associate Editor for Lewy Body Degeneration
Douglas R. Galasko,
La Jolla, California
Associate Editor for Frontal Temporal Degeneration
Bruce Miller,
San Francisco, California
Editorial Advisory Board
Alexander P. Auchus
Memphis, Tennessee
Cornelia Beck
Little Rock, Arkansas
Linda Boise
Portland, Oregon
Amy Borenstein
Tampa, Florida
John Vaughan Bowler
London, UK
John C.S. Breitner
Seattle, Washington
Henry Brodaty
Randwick, Australia
Owen Carmichael
Davis, California
Christopher Chen
Singapore
Jeffrey L. Cummings
Los Angeles, California
Steven T. DeKosky
Pittsburgh, Pennsylvania
Rachelle S. Doody
Houston, Texas
Sarah Tomaszewski Farias
Sacramento, California
Nick Fox
London, UK
Giovanni B. Frisoni
Brescia, Italy
James Galvin
St. Louis, Missouri
Serge G. Gauthier
Quebec, Canada
Ladson Hinton
Sacramento, California
Akira Homma, MD
Tokyo, Japan
William Jagust
Berkeley, California
David S. Knopman
Rochester, Minnesota
Amos D. Korczyn
Ramat Aviv, Israel
Walter Kukull
Seattle, Washington
Alan J. Lerner
Cleveland, Ohio
Constantine G. Lyketsos
Baltimore, Maryland
Carlos A. Mangone
Buenos Aires, Argentina
Jennifer Manly
New York, New York
Ian McKeith
Newcastle upon Tyne, UK
Kenichi Meguro
Sendai, Japan
Jim Mortimer,
Tampa, Florida
Dan Mungas,
Sacramento, California
Ricardo Nitrini
Sao Paulo, Brazil
John Olichney
Sacramento, California
George Perry
San Antonio, Texas
Ronald C. Petersen
Rochester, Minnesota
Bruce Reed
Martinez, California
Alex E. Roher
Sun City, Arizona
Vorapun Senanarong
Bangkok, Thailand
Mark A. Smith
Cleveland, Ohio
Reisa Sperling
Boston, Massachusetts
Takeshi Tabira
Aichi, Japan
Gunhild Waldemar
Copenhagen, Denmark
Anders Wallin
Goteburg, Sweden
Peter J. Whitehouse
Cleveland, Ohio
Founding Editors
Steven S. Matsuyama and Lissy F. Jarvik (1987-1992)
| 
